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The human genome represents a fossil record of ancient retroviruses that once replicated in the ancestors of
contemporary humans. Indeed, approximately 8% of human DNA is composed of sequences that are recognizably
retroviral. Despite occasional reports associating human endogenous retrovirus (HERV) expression with human
disease, almost all HERV genomes contain obviously inactivating mutations, and none are thought to be capable of
replication. Nonetheless, one family of HERVs, namely HERV-K(HML-2), may have replicated in human ancestors less
than 1 million years ago. By deriving a consensus sequence, we reconstructed a proviral clone (HERV-KCON) that likely
resembles the progenitor of HERV-K(HML-2) variants that entered the human genome within the last few million years.
We show that HERV-KCON Gag and protease proteins mediate efficient assembly and processing into retrovirus-like
particles. Moreover, reporter genes inserted into the HERV-KCON genome and packaged into HERV-K particles are
capable of infectious transfer and stable integration in a manner that requires reverse transcription. Additionally, we
show that HERV-KCON Env is capable of pseudotyping HIV-1 particles and mediating entry into human and nonhuman
cell lines. Furthermore, we show that HERV-KCON is resistant to inhibition by the human retrovirus restriction factors
tripartite motif 5a and apolipoprotein B mRNA-editing enzyme, catalytic polypeptide-like (APOBEC) 3G but is inhibited
by APOBEC 3F. Overall, the resurrection of this extinct infectious agent in a functional form from molecular fossils
should enable studies of the molecular virology and pathogenic potential of this ancient human retrovirus.
Citation: Lee YN, Bieniasz PD (2007) Reconstitution of an infectious human endogenous retrovirus. PLoS Pathog 3(1): e10. doi:10.1371/journal.ppat.0030010
Introduction
A characteristic that is unique to retroviruses is their
propensity to integrate their genomes into host-cell DNA as
an essential part of their replication cycle. Thus, if the target
cell population of a given retrovirus includes germ cells or
their progenitors, retroviral genomes can be inherited in a
Mendelian manner as so-called ‘‘endogenous’’ forms (see [1]
for review). Indeed, endogenous retroviruses have accumu-
lated over time in the genomes of many organisms and are
extraordinarily common in mammals, comprising approx-
imately 8% of human DNA [2]. Nonetheless, while some
avian, murine, and primate species harbor replication-
competent retroviruses within their genomes, intact retro-
viruses are relatively infrequent and almost all endogenous
retroviruses are obviously defective due to the presence of
stop codons and frameshifts in one or more genes.
Among the numerous families of defective human endog-
enous retroviruses (HERVs) found in modern human DNA,
the human mouse mammary tumor virus–like 2 (HML-2)
subfamily of HERV-K proviruses is of special interest. Even
though replication-competent forms of HERV-K(HML-2)
have not been found, some proviruses were deposited in
the human genome after speciation and represent some of
the youngest HERVs known [3–6]. Also, occasional reports
link their expression with human disease [7]. The age of an
endogenous provirus can be roughly estimated by comparing
sequence of the two long terminal repeats (LTRs). At
integration, the two proviral LTRs should be identical, but
during host DNA replication, each LTR independently
accumulates mutations as a function of age, and it is
estimated that one difference between two LTRs should
occur every approximately 200,000 to 450,000 y. Several
HERV-K(HML-2) proviruses have been identiﬁed in human
DNA that have less than ﬁve differences between the two
LTRs, suggesting deposition perhaps less than 1 million y ago
[3–6]. HERV-K(HML-2)–related proviruses are found only in
Old World primates genomes, and many are unique to
humans, with nonhuman primate genomes containing empty
preintegration sites at orthologous loci. Compellingly, poly-
morphism exists in humans with respect to the presence or
absence of proviruses at some HERV-K integration sites,
indicating insertion relatively recently in human evolution
[3–6]. Furthermore, many of the younger HERV-K(HML-2)
proviruses contain a subset of open reading frames (ORFs)
with a few or no mutations [3,6,8]. However, all known HERV-
K proviruses are replication defective.
There are several ways in which a defective provirus can
proliferate in a host’s genome, including via exogenous
infection events following complementation in trans, where
functional proteins are supplied by other endogenous or
Editor: Eddie C. Holmes, The Pennsylvania State University, United States of
America
Received October 13, 2006; Accepted December 13, 2006; Published January 26,
2007
Copyright:  2007 Lee and Bieniasz. This is an open-access article distributed
under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the
original author and source are credited.
Abbreviations: APOBEC, apolipoprotein B mRNA-editing enzyme, catalytic
polypeptide-like; AZT, azidothymidine; CA, capsid; CMV, cytomegalovirus; GFP,
green fluorescent protein; HERV, human endogenous retrovirus; HML-2, human
mouse mammary tumor virus–like 2; LTR, long terminal repeat; MUV, murine
leukemia virus; ORF, open reading frame; TRIM5a, tripartite motif 5a; VLP, virus-like
particle; VSV, vesicular stomatitis virus
* To whom correspondence should be addressed. E-mail: pbienias@adarc.org
PLoS Pathogens | www.plospathogens.org January 2007 | Volume 3 | Issue 1 | e10 0119exogenous viruses. Alternatively, for some retroelements,
envelope-independent retrotransposition can occur in cis,
where an element copies itself and inserts into a new genomic
locus within the same cell, forgoing the normal extracellular
phase of the retroviral life cycle. Defective proviruses can also
be proliferated as a result of long interspersed element
retrotransposition [9]. However, most HERV-K(HML-2) rep-
lication appears to have been a consequence of autonomous
infection by extracellular virions [10,11]. This conclusion is
based on the comparatively low number of stop codons and
ratio of nonsynonymous to synonymous changes (dN/dS) in
HERV-K ORFs, indicating a purifying selection on all
proteins. Notably, this ﬁnding holds for HERV-K Env [10],
which should be required for replication that includes an
extracellular step but not for any other mode of provirus
proliferation.
Ancient retroviruses are of interest, in part because they
likely imposed selective pressure on host defenses in human
ancestors. Indeed, the tripartite motif (TRIM) 5a and
apolipoprotein B mRNA-editing enzyme, catalytic polypep-
tide-like (APOBEC) 3 proteins that provide part of the host
defense against modern retroviruses have been under
positive selection for much of primate evolution [12–16]. As
a retrovirus that appears to have replicated in the ancestors
of modern Old World monkeys, apes, and humans, HERV-K
may be partly responsible for this pressure. Moreover, it is
conceivable that HERV-K exists today in an undetected
replication-competent form in rare humans [4]. However, no
studies of the virology or pathogenic potential of this ancient
human virus have been possible because a contemporary,
replication-competent HERV-K strain has not been identiﬁed
and may not exist at all.
Despite some functional degradation due to mutation
during deposition or during human DNA replication, HERV-
K(HML-2) proviruses that have been deposited in human
DNA in the past few million years should be reasonably well
preserved and have relatively few inactivating mutations.
Indeed, various studies have shown that individual proteins
from certain HERV-K proviruses can function in vitro [17–
25]. We reasoned that it might be possible to resurrect HERV-
K(HML-2) in replication-competent form using proviruses
that are thought to have most recently entered the human
genome as a template. Therefore, we constructed a HERV-K
strain whose genome sequence is a consensus of a subset of
HERV-K(HML-2) proviruses. Importantly, we demonstrate
that all viral proteins necessary for viral replication encoded
by this provirus are functional and that proteins and genomes
based on the reconstructed HERV-K(HML-2) viral genome
can be used to generate infectious exogenous retrovirus
particles.
Results
Design and Construction of a Consensus HERV-K
Genome (HERV-KCON)
Initially, our attempts to construct an infectious HERV-K
provirus were based on the sole HERV-K provirus (HERV-
K113) that has apparently intact ORFs for all viral proteins
[6]. This provirus, believed to be among the youngest human-
speciﬁc HERV-K proviruses, is present in the genomes of a
minority of humans. Unfortunately, construction of Gag,
Gag-protease (PR), and Gag-PR-Pol expression plasmids
based on HERV-K113 resulted in proteins that were poorly
expressed and were inefﬁciently processed and released as
virus-like particles (VLPs) (unpublished data). Thus, because
presence of intact ORFs did not necessarily imply intact
function, we took an alternative approach. Speciﬁcally, we
adopted a strategy that was based on the assumption that any
inherent replication defects that are encoded within HERV-
K(HML-2) proviruses present in contemporary human DNA
are either unique to each provirus or shared only by a
minority of recently integrated proviruses. If this assumption
was correct, then each individual defect should be absent
from a sequence representing the consensus of a collection of
proviruses, even if each provirus that contributes to the
consensus is defective.
We selected a group of ten full-length HERV-K(HML-2)
proviruses to derive a consensus HERV-K sequence. Specif-
ically, the ten proviruses with the best scores following
BLAST searching of human DNA with full-length HERV-
K113 sequence were chosen. As well as HERV-K113 itself, this
search yielded HERV-K101, HERV-K102, HERV-K104,
HERV-K107, HERV-K108, HERV-K109, HERV-K115, HERV-
K11p22, and HERV-K12q13. All of these proviruses are
known to be unique to humans, indicating integration into
the germ-line within the last 6 million y, when the human
lineage is believed to have diverged from the chimpanzee
lineage [3–6]. Moreover, several show insertional polymor-
phism in humans, with intact preintegration sites present in a
fraction of the human population, suggesting even more
recent replication. While all except HERV-K113 encoded an
obvious defect in at least one ORF, all of the selected
proviruses also had an intact ORF for at least one of the
putative HERV-K proteins (Figure 1A).
The nucleotide encoded by the majority of each of the ten
proviruses was deduced for each of 9,472 nucleotide positions
to derive HERV-KCON. Thereafter, using a set of synthetic,
approximately 60 base oligonucleotides spanning the entire
HERV-KCON sequence and a PCR- based strategy to pro-
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Infectious HERV-K
Author Summary
Retrovirus genomes integrate into the genomes of host cells. If the
target cells of a particular retrovirus include germ-line cells, e.g.,
sperm or egg cells, then retroviral genomes can be inherited like
cellular genes. So-called ‘‘endogenous’’ retroviruses have accumu-
lated throughout evolution in the genomes of many organisms,
including humans. While all known endogenous retroviruses of
modern humans are unable to replicate as retroviruses, the human
genome represents a fossil record of ancient retroviruses that once
infected our ancestors. In this study, a collection of ‘‘dead’’
endogenous retroviral genomes in modern human DNA was used
to deduce the approximate sequence of an ancestral retrovirus,
human endogenous retrovirus (HERV)-K, that is now thought to be
extinct. A pseudo-ancestral HERV-K DNA sequence was synthesized
and used to produce viral proteins and RNA that could reconstitute
the HERV-K replication cycle. Thus, the replication and biology of a
once-extinct retrovirus can now be studied in the laboratory.
Interestingly, reconstituted HERV-K replication experiments, and
comparison of the reconstituted HERV-K DNA sequence with the
dead HERV-Ks in modern human DNA, suggests that HERV-K may
have been extinguished in humans in part by host defenses that
induce mutation of retroviral DNA and that the reconstitution of the
pseudo-ancestral HERV-K reversed these changes.gressively link them together, we ﬁrst constructed a plasmid
containing the HERV-KCON proviral genome. The complete
proviral consensus sequence and the viral proteins that it
encodes are shown in Figure S1. As expected, the HERV-
KCON sequence was positioned close to the root of a
phylogenetic tree constructed using HERV-KCON itself and
each of the ten proviruses used to derive it (Figure 1B). Thus,
we reasoned that HERV-KCON represented a reasonable
approximation to the ancestor of HERV-K sequences that
integrated into the human genome within the past few
million years and might, therefore, be capable of replication.
Interestingly, pairwise comparisons indicated that the ma-
jority of nucleotide differences between HERV-KCON and
each of the ten contributing proviruses were either G-to-A or
C-to-T changes, or vice versa (Figure 1C). This ﬁnding hints at
a possible role of cytidine deaminases in driving HERV-K
evolution in humans, and perhaps contributing to the
inactivation of contemporary proviruses.
Particle Assembly and Release by HERV-KCON Gag, Gag-PR,
and Gag-PR-Pol Proteins
To determine whether the major HERV-KCON structural
proteins and enzymes were capable of assembling into
retrovirus-like particles, we constructed plasmids expressing
the consensus Gag, Gag-PR and Gag-PR-Pol ORFs. The
HERV-K genome has an unusual nucleotide composition in
that it is relatively A-rich. This feature, which is also
characteristic of lentiviruses such as HIV-1, is partly
responsible for the nuclear retention of HIV-1 mRNAs and
contributes to the requirement for Rev in mediating export
of incompletely spliced HIV-1 transcripts. Indeed, HERV-K
encodes a functional ortholog of the Rev protein, termed K-
Rev or Rec, that mediates nuclear export of HERV-K RNAs
[18–20,26]. Therefore, because of the likely requirement for a
Rev-like post-transcriptional activator for efﬁcient HERV-K
mRNA export, cDNAs encoding the HERV-KCON structural
proteins were inserted into a previously described expression
Figure 1. Design and Analysis of a Consensus HERV-K Provirus
(A) Diagram of HERV-K(HML-2) provirus. ORFs are depicted as boxes. Proviruses used in the design of HERV-KCON that contain intact versions of Gag,
protease, Pol, and Env are listed under each ORF (*K108 encodes a full-length Pol ORF, but a presumed essential YIDD motif is mutated).
(B) Phylogenetic analysis of HERV-KCON and the ten proviruses used to generate it, constructed using Kimura 2-parameter algorithm in the TreeMaker
program after gap-stripping the sequence alignment (http://www.hiv.lanl.gov/content/hiv-db/CONTAM/TreeMaker/TreeMaker.html).
(C) Comparison of HERV-KCON with the ten HERV-K proviruses. Each contributing provirus was compared to HERV-KCON using HYPERMUT, and the
number of nucleotide differences for each provirus relative to HERV-KCON is plotted.
doi:10.1371/journal.ppat.0030010.g001
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Infectious HERV-Kvector, termed pCRV1 [27], that provides an HIV-1 Rev
response element to the expressed mRNA in cis and the HIV-
1 Rev protein in trans.
Transfection of pCRV1-based plasmids expressing HERV-
KCON Gag, Gag-PR, or Gag-PR-Pol resulted in the expression
of a protein of approximately 70 to 80 kDa, detected by
Western blotting using a commercially available antibody
raised against HERV-K Gag (Figure 2A). This approximated
to the size expected (74 kDa) of the intact HERV-K Gag
precursor. A concurrent analysis of proteins pelleted from
culture supernatant through 20% sucrose revealed that Gag
expression alone could efﬁciently generate extracellular
particles (Figure 2A). In addition to the 74-kDa Gag
precursor, a protein of approximately 40 kDa that reacted
with the HERV-K Gag antibody was detected in lysates of cells
transfected with Gag-PR and Gag-PR-Pol expression plas-
mids. While the precise identity of the 40-kDa protein is
unknown, it likely represents a proteolytically processed form
of Gag and, therefore, this ﬁnding suggested that the HERV-
KCON protease was active. Consistent with this notion,
Western blot analysis of extracellular particles generated
following Gag-PR and Gag-PR-Pol expression did not contain
detectable Gag precursor but did contain the 40-kDa
apparently processed Gag species (Figure 2A).
Analysis of total protein in extracellular particles by SDS-
PAGE and silver staining revealed that HERV-KCON Gag
expression alone generated particles composed of a single
dominant protein of the size predicted for the HERV-K Gag
precursor, as expected (Figure 2B). Particles generated by
Gag-PR contained a dominant protein of 30 kDa, which based
on previous studies likely represents HERV-KCON capsid (CA)
[24,28,29]. A smaller protein or proteins of 20 kDa were also
observed in Gag-PR particles, which presumably represents
other mature Gag processing product or products such as
matrix or nucleocapsid (Figure 2B). Additionally, a protein of
40 kDa that likely corresponded to the 40-kDa band detected
by Western blotting was also observed on silver-stained gels.
However, the 40-kDa protein was a minor species in Gag-PR
particles, and it is therefore possible that this protein
represents a partly processed intermediate. HERV-K Gag-
PR-Pol expression also yielded particles containing the same
apparently processed Gag proteins as those generated by
Gag-PR but at slightly lower levels (Figure 2B). The
appearance of the 30-kDa putative CA protein on silver-
stained gels (Figure 2C) was abolished when three predicted
active site residues (Asp-Thr-Gly) in the HERV-KCON protease
ORF were mutated to Ala-Ala-Ala. Additionally, a higher-
molecular-weight protein, possibly representing the Gag-PR
precursor, was observed in particles harvested from cells
expressing the mutant Gag-PR protein (Figure 2C). Although
their low abundance relative to contaminating extraneous
cellular proteins and the lack of available antibodies
precluded unambiguous identiﬁcation of Pol proteins in
SDS-PAGE analyses of HERV-KCON VLPs, supernatants of
293T cell cultures transfected with the HERV-KCON Gag-PR-
Pol expression plasmid contained quite high levels of reverse
transcriptase activity, as detected by an ELISA-based assay
designed for the detection of HIV-1 reverse transcriptase
(Figure 2D). As controls, no reverse transcriptase activity was
detected in cultures transfected with HERV-KCON Gag or
Gag-PR expression plasmids.
Coexpression of HERV-KCON Gag and Gag–green ﬂuores-
cent protein (GFP) fusion proteins in 293T cells revealed that
HERV-KCON Gag localized predominantly to the plasma
membrane, where numerous ﬂuorescent puncta were ob-
served (Figure 2E). Moreover, electron microscopic examina-
tion of 293T cells expressing HERV-KCON Gag-PR revealed
the presence of cell-associated retrovirus-like particles and
structures that appeared to represent assembly intermediates
(Figure 2F). Most particles appeared as 100 to 150 nm,
apparently spherical immature virions, with a minority
assembled as aberrant particles that appeared as two or
more connected, partly assembled, virions. While we did not
observe unambiguously mature virions associated with the
surface of Gag-PR–expressing cells, it is possible that full
maturation, which was clearly indicated by the biochemical
analysis of extracellular VLPs (Figure 2B and 2C), occurred
only after the completion of particle release from cells.
Completely or incompletely assembled particles appeared
exclusively at the plasma membrane with a morphology
resembling partly assembled alpharetroviruses or gammaret-
roviruses. Even though betaretroviruses represent HERV-Ks
closest exogenous retrovirus relatives, no cytoplasmic, non-
enveloped particles, typically observed in betaretroviruses,
were found.
Generation of HERV-KCON–Based Infectious Virions
To determine whether particles containing the HERV-
KCON genome, Gag, PR, and Pol proteins were capable of
infectious transfer of the HERV-KCON genome to target cells,
we inserted a reporter gene cassette (cytomegalovirus [CMV]-
GFP) into the env gene of the HERV-KCON proviral plasmid.
Additionally, because the HERV-K LTR promoter is ex-
tremely weak in 293T cells (unpublished data), we replaced
U3 sequences 59 to the TATA box with corresponding
sequences from the promoter/enhancer of CMV. This con-
struct was named CHKCG (Figure 3A). As expected, trans-
fection of this Env-defective CHKCG construct in 293T cells
resulted in GFP expression in transfected 293T cells, but
inoculation of target cells with 0.2-lm ﬁltered supernatant
harvested from these cells did not result in infectious transfer
of the reporter gene. However, when an envelope protein
from vesicular stomatitis virus (VSV-G) was expressed in trans,
clear GFP expression was observed in rare foci of target cells
inoculated with ﬁltered supernatant from CHKCG-trans-
fected cells. Moreover, by boosting HERV-K protein expres-
sion, the yield of infectious virions was improved (Figure 3B–
3E). Indeed, when K-Rev/Rec was expressed in trans with
CHKCG and VSV-G, infectious particle yield was in excess of
10
2 IU/ml (Figure 3B and 3E). Similarly, when the HERV-KCON
Gag-PR-Pol expression plasmid was provided in trans, the
yield of infectious particles also increased to greater than 10
2
IU/ml (Figure 3D). The combined expression of CHKCG,
VSV-G, HERV-K Gag-Pol, and K-Rev/Rec yielded the highest
infectious titers (up to 10
3 IU/ml, Figure 3C and 3E), and this
combination of plasmids was used to generate infectious
HERV-KCON(VSV-G) pseudotyped particles in subsequent
studies. While this infectious titer is low compared to that
generated by many exogenous retroviruses (e.g., murine
leukemia virus [MLV] and HIV-1), the yield of infectious
HERV-K particles was of the same order as that obtained with
similarly constructed human T-cell lymphotropic virus-I–
based vector systems ([30] and unpublished data).
To verify that transfer of reporter gene expression by
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Infectious HERV-KFigure 2. Assembly, Processing, and Release of HERV-K Virus-Like Particles
(A–D) 293T cells were transfected with Gag-, Gag-PR–, or Gag-PR-Pol–expressing vectors.
(A) Western blot analysis of cell lysates (left) and virions (center and right) using a commercially available antibody to HERV-K Gag. Center shows VLPs
from 293T cells transfected with a plasmid-expressing Gag, and right shows VLPs from Gag-PR– and Gag-PR-Pol–expressing 293T cells. Decreasing
amounts of virion lysate (0.1, 0.05, or 0.025 ll for Gag; 0.4, 0.2, or 0.1 ll for Gag-PR and Gag-PR-Pol) were loaded to semiquantitatively estimate relative
levels of VLP production.
(B) Silver stain analysis of a 4% to 20% gradient SDS-PAGE gel loaded with VLPs harvested from 293T cells transfected with plasmids expressing Gag,
Gag-PR, Gag-PR-Pol, or empty plasmid control. An asterisk marks a nonspecific 66-kDa protein band, most probably BSA, that is abundant in the culture
medium.
(C) Silver stain analysis of VLPs harvested from 293T cells containing Gag, Gag-PR, Gag-PR-Pol, or Gag-PR(mut) encoding an active site mutation (DTG-
AAA) in protease. An asterisk marks a nonspecific 66-kDa protein band, most probably BSA, that is abundant in the culture medium.
(D) Reverse transcriptase activity in culture supernatants of 293T cells transfected with empty pCRV1 (vector) or vectors expressing HERV-KCON Gag,
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Infectious HERV-KHERV-KCON particles was via bona ﬁde retrovirus-based
transduction, we inoculated 293T cells with HERV-
KCON(VSV-G) particles containing the CHKCG genome in
the presence of azidothymidine (AZT), a reverse transcriptase
inhibitor. AZT is a thymidine analog chain terminator and is
known to inhibit reverse transcriptases from a wide variety of
retroviruses [31]. As can be seen in Figure 3F, application of
AZT to target cells inhibited HERV-K–mediated reporter
gene transduction by approximately 30-fold. Thus, reporter
gene transfer by HERV-KCON was clearly dependent on
reverse transcription.
Transduction by HERV-KCON Results in Bona Fide
Retroviral Integration
In some cases, low levels of reporter gene expression
mediated by retroviral gene transfer can be mediated by
reverse-transcribed but nonintegrated retroviral DNA, which
can exist as linear or circular forms in target cells [32–34].
However, these retroviral DNA forms are diluted during cell
division and eventually lost. Stable retrovirus-mediated gene
transfer that is transferred to both daughter cells requires
that retroviral DNA be integrated into the target cell genome.
While the formation of clear multicellular foci of GFP-
positive cells suggested the reporter gene was maintained in
daughter cells, integration events are most effectively assayed
by daughter cell colony formation under antibiotic selection
using retroviral genomes that carry resistance markers.
Therefore, we constructed a variant of the CHKCG genome
(Figure 3A) in which the CMV-GFP cassette was replaced by
one carrying a CMV-driven puromycin resistance gene,
termed CHKCP. We generated HERV-KCON(VSV-G) particles
carrying CHKCP in the same way as previously (Figure 3) and
found that puromycin-resistant colonies were formed follow-
ing exposure of 293T target cells to these virions and
antibiotic selection (Figure 4A). Indeed, the infectious titers
of puromycin resistance transducing particles were similar to
that of GFP-transducing particles.
To further demonstrate that HERV-KCON genomes were
capable of integration, hamster (CHO745) cells were infected
with HERV-KCON(VSV-G) particles carrying the CHKCP
genome and four single cell clones were derived from the
resulting puromycin-resistant cell population. Cellular ge-
nomic DNA was extracted following expansion of the clones
for 2 wk in culture and analyzed for the presence of
integrated HERV-K DNA using a PCR-based strategy (Figure
4B). Hamster CHO745 cells were used for these experiments,
because they were found to be as sensitive as human cells to
HERV-KCON(VSV-G) infection (see below), but unlike human
cells, they lack endogenous HERV-K proviruses that would
complicate detection and analysis of de novo HERV-K
integration events. As can be seen in Figure 4C, PCR analysis
using HERV-K gag speciﬁc PCR primers revealed that each of
the CHKCP-transduced clones, but not parental CHO745
cells, carried HERV-K DNA. Next, sequences ﬂanking the
Figure 3. Generation of Single Cycle Infectious Virions Containing HERV-
KCON Genomes and Gag-PR-Pol
(A) Schematic representation of the HERV-KCON–based CHKCG genome.
Changes to HERV-KCON are depicted in white boxes. The 59 LTR was
modified to include the CMV promoter inserted in place of the U3 region.
The Env ORF, which now contains CMV-GFP, is disrupted.
(B and C) Photomicrographs of 293T cell monolayers after infection with
CHKCG-carrying HERV-KCON(VSV-G) pseudotyped virions, which were
generated following transfection of 293T cells with the indicated plasmid
mixtures.
(D and E) Infectious titers of HERV-KCON(VSV-G) pseudotyped virions
generated following transfection with the indicated plasmid mixtures in
the absence (D) or presence (E) of K-Rev/Rec and using 293T target cells.
GFP-positive foci were enumerated visually and expressed as infectious
units per milliliter of virion-containing supernatant.
(F) Infectious titers of CHKCG containing HERV-KCON(VSV-G) using 293T
target cells in the presence or absence of 50 lM AZT.
All data are representative of at least three experiments.
doi:10.1371/journal.ppat.0030010.g003
Gag-PR, or Gag-PR-Pol proteins, as indicated. Enzymatic activity was determined relative to a recombinant HIV-1 reverse transcriptase standard andi s
representative of three experiments. Supernatants from 293T cells transfected with an HIV-1–based proviral plasmid are included for comparison.
(E) Two representative 293T cells transfected with HERV-KCON Gag and Gag-GFP expression plasmids. Cells were fixed 18 h post-transfection, and nuclei
were stained with DAPI (blue) prior to visualization by deconvolution microscopy. Top, Images acquired at the mid-section of the cell to show
localization of Gag-GFP proteins; bottom, focused on the bottom of the cell to show accumulated VLPs at the cell–coverslip interface.
(F) Gallery of electron micrographs of 293T cells transfected with a Gag-PR–expressing plasmid. Black scale bars in the upper and middle panels
represent 500 nm, while scale bars in the lower two panels represent 100 nm.
doi:10.1371/journal.ppat.0030010.g002
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Infectious HERV-Kintegrated provirus were identiﬁed using a PCR-based
strategy (GenomeWalker kit; Clontech, http://www.clontech.
com) and in each case revealed the presence of a six-
nucleotide duplicated sequence immediately ﬂanking the
provirus (Figure 4D). For three CHKCP-transduced CHO745
cell clones, PCR primers were designed that targeted hamster
DNA sequences ﬂanking the integrated HERV-KCON provirus
(Figure 4B and 4E), and these were used to authenticate the
presence of the intact preintegration site in uninfected
hamster cells (e.g., Figure 4E). Moreover, PCRs using
combinations of the hamster DNA-speciﬁc and HERV-K–
speciﬁc PCR primers were used to authenticate the presence
HERV-K provirus/hamster cellular DNA junctions in three of
the CHKCG-transduced clones (e.g., Figure 4E).
Overall, these experiments demonstrate that HERV-K
genomes can be replicated via exogenous infection in a
reverse transcriptase–dependent manner, resulting in stable
and authentic integration into the target cell genome.
HERV-KCON Tropism
Next, we determined whether VSV-G pseudotyped HERV-
KCON particles could transduce reporter genes into cells
other than 293T and CHO745. As can be seen in Figure 5A,
several target cells of human, squirrel monkey, feline, and
rodent origin could be infected by HERV-KCON(VSV-G).
However, it was noticeable that murine NIH3T3 cells and
squirrel monkey Pindak cells were somewhat less sensitive to
HERV-KCON(VSV-G), compared to the human and feline
cells. The human cells were each quite similar in their
sensitivity to HERV-KCON(VSV-G) even though 293T cells
display little or no TRIM5a-dependent resistance to retro-
viruses such as EIAV or N-tropic MLV, while TE671 and
HT1080 exhibit strong TRIM5a-dependent resistance to N-
tropic MLV and EIAV. This ﬁnding suggested that HERV-
KCON may not be sensitive to human TRIM5a.
Additionally, to test whether the HERV-KCON envelope
sequence was functional, it was inserted into the HIV-1–based
expression vector pCRV1 and expressed along with HIV-1
Gag-Pol proteins and the packageable GFP-expressing HIV-1
vector CSGW. This transfection mixture should generate
Figure 4. Transduction Mediated by HERV-KCON Gag-PR-Pol and
Genomes Results in Stable Proviral Integration
(A) Puromycin-resistant colonies of 293T cells infected with either VSV-G
pseudotyped (left) or Env defective (right) virions carrying the CHKCP
genome. Infected 293T cells were selected in 0.5 lg/ml puromycin for 2
wk and then fixed and stained to reveal colonies of viable cells. Data are
representative of at least three experiments.
(B) Experimental strategy for detection of HERV-KCON proviruses in
CHO745 cells using PCR primers targeted to HERV-KCON Gag and LTR
sequences, or flanking hamster DNA sequences.
(C) PCR amplification of HERV-KCON gag DNA using Gag-S and Gag-AS
primers in four expanded clones of puromycin-resistant CHO745 cells
transduced with CHKCP-containing HERV-KCON(VSV-G) particles.
(D) Nucleotide sequences at the 59 and 39 ends of integrated CHKCP
proviral DNA, revealing six nucleotide duplicated sequences at the
CHKCP integration sites.
(E) Verification of the presence and absence of an integrated provirus
and the empty preintegration site in CHKCP-transduced and naı ¨ve
CHO745 cells using combinations of HERV-K and hamster DNA targeted
PCR primers (see [B] for primer design strategy). DNA templates and PCR
primer pairs used are indicated above each lane, and the expected PCR
product size is given below each lane. A representative analysis of a
single CHKCG-carrying CHO745 cell clone is shown; similar results were
obtained with two additional clones. Uninfected CHO745 cells and
human 293T cells serve as controls.
doi:10.1371/journal.ppat.0030010.g004
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Infectious HERV-KHIV-1 particles, putatively pseudotyped with the HERV-KCON
envelope protein. Notably, HIV(HERV-KCON) particles were
capable of infecting 293T cells, with titers of around 3 3 10
2
IU/ml (Figure 5B), while particles generated in the absence of
HERV-KCON Env were noninfectious. Inoculation of cells
from a small panel of mammalian species revealed that
several, including those of human, squirrel monkey, murine,
and feline origin, could be infected with HIV-1(HERV-KCON)
pseudovirions (Figure 5B). While attempts were made to
generate infectious particles that contained both HERV-
KCON cores and Env proteins, we were not able to detect
infection events using this combination. Nevertheless, these
experiments indicate that the HERV-KCON genome contains
all functional components required to complete an exoge-
nous retroviral replication cycle.
Sensitivity of HERV-KCON to Retrovirus Restriction Factors
To test the sensitivity of HERV-K to retrovirus restriction
factors that it might encounter in human cells and might be
responsible for attenuation or extinction of replication
therein, we ﬁrst challenged unmodiﬁed, or human TRIM5a-
expressing, hamster (CHO)-derived cell lines with HERV-
KCON(VSV-G). Despite the fact that the human TRIM5a-
expressing cell line was greater than 100-fold resistant to N-
tropic MLV relative to the control cell line or B-tropic MLV
(Figure 6A), HERV-KCON infected unmanipulated and human
TRIM5a-expressing cells with nearly identical efﬁciency
(Figure 6B). Additionally, CHO cells expressing rhesus
macaque TRIM5a or the unique owl monkey variant of
TRIM5 (TRIM-Cyp) were also similarly sensitive to HERV-
KCON(VSV-G) infection as unmanipulated control cells
(Figure 6A). This was despite the fact that CHO cells
expressing rhesus monkey TRIM5a and owl monkey TRIM-
Cyp were about 30-fold and 100-fold, respectively, resistant to
HIV-1 infection compared to HIV-1 carrying an SIVMAC CA
(Figure 6A).
Next, we tested whether APOBEC3G and APOBEC3F were
capable of inhibiting HERV-KCON replication. These cytidine
deaminases are the major inhibitors of Vif-deﬁcient HIV-1
infectivity, although APOBEC3G is a signiﬁcantly more
potent inhibitor of HIV-1 replication than is APOBEC3F.
Surprisingly, APOBEC3G expression during particle produc-
tion only marginally inhibited HERV-KCON(VSV-G) infection,
while APOBEC3F more potently reduced infectivity, reducing
titers by about 50-fold (Figure 6C). This was despite
approximately equivalent levels of HERV-KCON Gag expres-
sion and generation of viral particles in the presence or
absence of APOBEC3G or APOBEC3F (Figure 6D). Overall, of
the restriction factors tested that are likely to be encountered
in human cells, HERV-KCON appeared to be resistant to
human TRIM5a and APOBEC3G proteins but sensitive to
APOBEC3F.
Discussion
Here, we constructed a HERV-K provirus whose sequence
resembles that of an ancestral human-speciﬁc HERV-K(HML-
2). We demonstrate that all viral proteins encoded by this
provirus are capable of functioning in the context of a
retroviral replication cycle. While some recent studies have
reconstituted ‘‘live’’ viruses from synthetic DNA [35,36], this
and a similar study of HERV-K which appeared online while
this manuscript was in review [37] are the ﬁrst examples in
which the replication cycle of a virus has been reconstituted
using a group of sequences that represent ancient fossils and
are demonstrably defective. The methods used here are
conceptually similar to those applied to the reconstitution of
the transposable element Sleeping Beauty, in which a func-
tional Tc1/mariner-type transposon present only in defective
forms in ﬁsh DNA was reconstituted [38]. Successful
reconstitution in that study was achieved using a majority
consensus sequence to synthesize an active trasposase protein
and selecting cis-acting sequences from a representative
element that closely resembled those of the majority
consensus sequence [38].
HERV-K likely replicated in the ancestors of humans for
approximately 30 million y but is not known to exist as a
replication-competent virus today. Indeed, it is possible, even
likely, that HERV-K has not replicated as a retrovirus for
hundreds of thousands of years. It was not obvious what the
optimal approach to reconstitute functional HERV-K se-
quences would be, since variation in HERV-K sequence could
arise through natural variation via error-prone reverse
transcription, mutational degradation after deposition in
the primate germ-line, or cytidine deamination before,
during, or after during initial germ-line deposition (see
below). Moreover, it was possible that the population of
proviruses accessible to us in modern DNA represented a
highly biased sample of HERV-K genomes where defects
Figure 5. HERV-KCON Tropism
(A) Human, squirrel monkey, feline, hamster, or murine cells were
infected with VSV-G pseudotyped HERV-KCON particles. Two days
postinfection, GFP
þ foci were quantified microscopically, and titers are
expressed as number of infectious units (i.u.) per milliliter of virus-
containing supernatant applied.
(B) Human, squirrel monkey, feline, or murine cells were infected with
HERV-KCON Env pseudotyped HIV-1 particles as in (A). Two days
postinfection, GFP-positive foci were quantified.
All data are representative of at least three experiments.
doi:10.1371/journal.ppat.0030010.g005
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Infectious HERV-Kmight have been positively selected during primate evolution.
Thus, rather than attempt reconstruct the evolutionary
history of HERV-K in primates, we adopted a conservative
approach to reconstitute functional sequences, selecting ten
proviruses that were most similar to a relatively young and
comparatively intact HERV-K provirus (HERV-K113), rea-
soning that these were the least likely to have undergone
substantial sequence degradation. Moreover, all of the
selected proviruses were unique to human DNA, and some
were polymorphic in humans, suggesting comparatively
recent replication. While it was possible that all of the
selected proviruses would have a common lethal defect, this
appeared not to be the case. Indeed, by compiling a simple
majority consensus sequence, we successfully removed indi-
vidual lethal defects represented in the group of proviruses
that contribute to the consensus sequence, allowing repli-
cation of the consensus genome in a bona ﬁde reverse
transcription–dependent manner that resulted in the stable
integration of HERV-KCON genomes into target cells. Analysis
of the replication cycle of HERV-KCON in human cells
allowed preliminary characterization of aspects of HERV-K
biology that have heretofore been refractory to investigation.
Assembly of HERV-K virions at the plasma membrane is
notable, given that the exogenous retroviruses that are most
closely related to HERV-K include mouse mammary tumor
virus and Mason-Pﬁzer monkey virus, both of which are
betaretroviruses that assemble complete capsids within the
cytoplasm of infected cells. Nonetheless, previous analyses
have suggested that the small number of human cell lines that
express HERV-K exhibit plasma membrane localized assem-
bly intermediates [28,29], as was observed here for HERV-
KCON. Moreover, previous work has shown that a single amino
acid mutation in MPMV Gag protein can change its assembly
characteristics from cytoplasmic to plasma membrane asso-
ciated assembly [39]. Thus, it should not be surprising that
HERV-K assembly appears morphologically different to that
of its betaretrovirus relatives.
Two major components of intrinsic defense against
retrovirus and retroelement replication in primate cells are
the TRIM5 and APOBEC3 gene products [40–42]. Analysis of
these genes in modern primates indicates that these genes
have likely been under positive selection pressure for
signiﬁcant portions of primate evolution [12–16]. As an
endogenous retrovirus that has also apparently replicated
exogenously and has been active for much of Old World
primate evolutionary history, HERV-K is an excellent
candidate for an agent that has imposed sustained evolu-
tionary pressure on antiretroviral defenses present in
modern primates. Nonetheless, HERV-K infection was not
inhibited by the TRIM5 proteins that were tested. In the case
of human TRIM5a, this was not unexpected, because HERV-
KCON was derived from human-speciﬁc proviruses that must,
by deﬁnition, have replicated in humans at some point in
their evolution and may, therefore, have evolved resistance to
human TRIM5a. However, HERV-KCON was also resistant to
rhesus monkey TRIM5a and also TRIM-Cyp, a form of TRIM5
that is unique to owl monkeys [43,44], a New World monkey
Figure 6. Effects of TRIM5 and APOBEC3 Proteins on HERV-KCON
Infectivity
(A) Unmanipulated CHO cells or variants stably expressing human
TRIM5a, rhesus monkey TRIM5a, or owl monkey TRIM-Cyp were infected
with VSV-G pseudotyped retroviral vectors that are sensitive to one or
more of the TRIM5 proteins (N-MLV or HIV-1) or TRIM5-resistant controls
(B-MLV or HIV-1 carrying SIVmac CA HIV(SCA)), as indicated. Two days
postinfection, the percentage of GFP
þ cells was determined using FACS.
(B) The same panel of CHO-derived TRIM5-expressing CHO cell lines were
inoculated with HERV-KCON(VSV-G). Two days postinfection, GFP
þ foci
were quantified.
(C) APOBEC3F and APOBEC3G expression plasmids were cotransfected
into 293T cells during generation of CHKCG-containing HERV-KCON(VSV-
G) particles. Fresh 293T cells were infected with the resulting viral
supernatant, and GFP
þ foci were quantified 2 d later.
(D) Western blot analysis, using the anti–HERV-K Gag antibody, of cell
and HERV-KCON virion lysates generated upon coexpression of APOBEC3F
or APOBEC3G, as indicated.
All data are representative of at least three experiments.
doi:10.1371/journal.ppat.0030010.g006
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Infectious HERV-Kspecies that does not carry HERV-K. At present, therefore,
there is no evidence that TRIM5 proteins and HERV-K have
exerted reciprocal evolutionary pressure during primate
evolution. However, analysis of CA sequences reconstructed
from more ancient groups of HERV-K proviruses and
inserted into HERV-KCON, as well as inclusion of more
TRIM5a variants, may be illuminating. The studies described
herein suggest that such approaches to study interactions
between ancient retroviruses and their hosts should be
feasible.
It was notable that the process of generating a consensus
HERV-K genome, in effect, primarily involved the replace-
ment of A and T nucleotides in modern defective proviruses
with G and C nucleotides, respectively. The position of the
consensus sequence near the root of the phylogenetic tree
suggests that a G or C ‘‘ancestral’’ state at many nucleotide
positions in human-speciﬁc HERV-K genomes has been
replaced by A and T nucleotides in modern defective
proviruses. While these results do not necessarily lead to
the conclusion that cytidine deaminases are responsible for
the reduction or extinction of HERV-K replication in
humans, they hint that this may have been the case. At a
minimum they suggest that cytidine deamination events have
impacted HERV-K evolution in humans. While G-to-A
changes were the most frequently represented in compar-
isons of HERV-KCON with contemporary proviruses, plus-
strand C-to-T changes also appeared to be overrepresented.
While most APOBEC-induced mutation is thought to result
from deamination of minus strand cytidines during reverse
transcription [45–48], at least some APOBEC proteins are
also are capable of inducing C-to-T changes on the plus
strand of proviruses, by catalyzing deamination of viral RNA
or perhaps dsDNA [49]. HERV-K replication was sensitive to
APOBEC3F but only marginally affected by APOBEC3G. This
was somewhat surprising and clearly distinguishes HERV-K
from Vif-deﬁcient HIV-1 which is more sensitive to APO-
BEC3G than to APOBEC3F [50–53]. Indeed, an overall view is
emerging that a variety of APOBEC3 proteins can be
selectively active against various retroelements and retro-
viruses [54] but HERV-K has yet to be analyzed. Of note is the
observation that the patterns of apparent cytidine deami-
nation events in modern HERV-K proviruses do not precisely
match those predicted if APOBEC3F was primarily respon-
sible for G-to-A and C-to-T mutation therein. Therefore,
further analysis of HERV-K sequences in humans and Old
World primates and the impact of their various APOBEC
proteins on HERV-KCON replication may illuminate an
evolutionary history of ancient host–retrovirus conﬂicts.
Materials and Methods
Derivation, analysis, and synthesis of HERV-KCON. The complete
HERV-K113 proviral sequence was used to search human genome
sequence using National Center for Biotechnology Information
nucleotide-to-nucleotide BLAST. Multiple entries of the same
HERV-K proviruses were identiﬁed by inspection of ﬂanking
genomic sequence and excluded, and the most recently sequenced
entries were used for the alignment. The top ten hits were aligned
using AlignX program of Vector NTI Advance 10.0.1 (Invitrogen,
http://www.invitrogen.com) to derive a consensus sequence that was
termed HERV-KCON. HERV-KCON sequence was compared to other
HERV-K(HML-2) proviruses using HYPERMUT (http://www.hiv.lanl.
gov/content/hiv-db/HYPERMUT/hypermut.html) [55].
The complete HERV-KCON proviral sequence was synthesized
using overlapping oligonucleotides of approximately 60 bases
spanning the entire genome. Oligonucleotides were assigned to 13
groups corresponding to 13 HERV-KCON fragments of approximately
700 nucleotides and assembled using sequential PCRs. In the ﬁrst
round, all oligonucleotides were included in the reaction and 15
cycles of synthesis were executed using Pfu DNA polymerase (94 8C
for 10 s, 45 8C for 20 s, 72 8C for 30 s). Thereafter, an aliquot of the
reaction product was subjected to ampliﬁcation using the 59 and 39
oligonucleotides in each group (94 8C for 20 s, 45 8C for 20 s, 72 8C for
3 min; 15 cycles). Fragments from regions of the HERV-K genome
lacking convenient restriction sites were assembled into longer
fragments of up to 1.5 kb via overlap extension PCR. A derivative
of the low-copy-number plasmid vector, pXF3, was derived by
inserting a synthetic oligonucleotide encoding the restriction sites
ClaI, XhoI, EcoRV, SpeI, AgeI, SacI, DraIII, XbaI, and NheI that
corresponded to convenient restriction sites in the HERV-KCON
genome. These were used to sequentially insert the various synthetic
DNA fragments, thereby generating the ﬁnal pXF3/HERV-KCON
proviral plasmid.
HERV-KCON–derived expression plasmids. CHKCG was created
from the pXF3/HERV-KCON proviral plasmid by ﬁrst replacing
HERV-K U3 sequences 59 to the TATA box with CMV promoter/
enhancer sequences using overlapping PCR and ClaI and EcoRV
restriction sites to generate pXF3/CMVP HERV-KCON. In parallel, an
EGFP cDNA (Clontech) was inserted into pCR3.1 (Invitrogen), and
then the CMVP-EGFP cassette was PCR ampliﬁed and inserted into
KpnI site of pXF3/CMVP HERV-KCON to create CHKCG. Similarly, a
Puro cDNA was digested from pMSCVPuro (Clontech) with HinDIII
and XbaI and inserted into pCR3.1. Thereafter, a CMVP-Puro
cassette was PCR ampliﬁed and cloned into pXF3/CMVP-HERV-
KCON to create the CHKCP genome.
Other HERV-K expression plasmids. pCRVI/Gag, pCRVI/Gag-PR,
and pCRVI/Gag-PR-Pol were generated by insertion of the respective
ORFs from pXF3/HERV-KCON into the NotI restriction site of pCRVI.
Similarly, a PCR-ampliﬁed HERV-KCON Env-encoding fragment was
inserted using EcoRI and NotI restriction sites, generating pCRVI/
Env. A mutant form of pCRVI/Gag-PR was generated by substituting
the conserved putative active site residues (DTG) to AAA. The two K-
Rev/Rec exons were PCR ampliﬁed from BAC RP11-33P21 (Invitro-
gen) containing the HERV-K108 sequence, which happens to encode
a K-Rev/Rec protein that is identical to the consensus sequence,
joined using overlapping PCR, and inserted into EcoRI and XhoI of
pCR3.1 to generate pCR3.1/K-Rev.
Cell lines and transfection. The 293T, MDCK, Pindak, TE671,
HeLa, CRFK, and HT1080 cells were maintained in DMEM
supplemented with 10% fetal calf serum and gentamicin. CHO745
cells and TRIM5-expressing derivatives were cultured in Ham’s F-12
medium with the same additives. The 293T cells were transfected in
10-cm plates at 6 3 10
6 cells per plate or in six-well plates at 1 3 10
6
cells per well using polyethylenimine as previously described [56].
Medium was changed 24 h after transfection, and virus-containing
supernatants were collected after an additional 24 h.
HERV-K protein analysis. The 293T cells were transfected with 10
lg of pCRVI/Gag, pCRVI/GagP-PR, pCRVI/Gag-PR-Pol, or pCRVI.
Two days after transfection, the supernatant was collected, ﬁltered
(0.2 lm), and ultracentrifuged through a 20% sucrose layer at
100,000g for 90 min at 4 8C. The pelleted VLPs and corresponding
transfected cells were resuspended in SDS-PAGE loading buffer and
separated on 10% SDS-PAGE gels (Bio-Rad, http://www.biorad.com).
Proteins were transferred onto nitrocellulose membrane and probed
with an anti–HERV-K Gag antibody (Austral Biologicals, http://www.
australbiologicals.com). Alternatively, VLPs were separated on 4% to
20% gradient or 10% SDS-PAGE gel (Bio-Rad) and silver stained
using a kit, as per the manufacturer’s instructions (Sigma-Aldrich,
http://www.sigmaaldrich.com).
Reverse transcriptase activity in 293T culture supernatants was
measured using a commercially available reverse transcriptase assay
(Cavidi, http://www.cavidi.se) in which BrdUTP is incorporated into a
plate-bound oligo(dT)/poly(rA) substrate. Thereafter, solid phase
polymerized BrdU is detected using an anti–BrdU–alkaline phospha-
tase conjugate and a colorimetric substrate. Activity is standardized
using a recombinant HIV-1 RT standard.
HERV-KCON and HIV-1(HERV-K) pseudotype infection assays. To
generate VSV-G pseudotyped HERV-KCON particles, 293T cells in six-
well plates were transfected with 1.3 lg of CHKCG or CHKCP, 1 lgo f
pCRVI/Gag-PR-Pol, 0.5 lg of pCR3.1/Rec, and 0.2 lg of VSV-G. Empty
control vectors were transfected when necessary. In some experi-
ments, 1 lg of plasmids expressing myc-tagged human APOBEC3F
and APOBEC3G [53] was also transfected. Alternatively, 293T cells in
10-cm dishes were transfected with 6.5 lg of CHKCG, 4 lg of pCRVI/
Gag-PR-Pol, 3 lg of pCR3.1/Rec, and 1.5 lg of VSV-G. At 24 h after
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Infectious HERV-Ktransfection, the transfection mixture was replaced with of fresh
media containing 5 lM sodium butyrate. To generate HIV-1 (HERV-
KCON) pseudotypes, 293T cells in 10-cm plates were transfected with 6
lg of HIV-1-GagPol, 6 lg of CSGW, and either 3 lg of pCRVI/HERV-
KCON Env or empty pCRVI as a control.
Filtered (0.2 lm) supernatant from HERV-KCON(VSV-G)– or HIV-
1(HERV-KCON)–producing cells was placed onto target cells seeded in
24-well plates along with fresh media in the presence of 5 lgo f
polybrene/ml for 24 h. Two days after infection, GFP
þ target cells
were quantiﬁed either by counting foci microscopically or by FACS
analysis. In some experiments, 50 lM AZT was added to the medium
at the time of infection.
Analysis of de novo integrated HERV-KCON proviral DNA.
CHO745 cells were infected with CHKCP-carrying HERV-
KCON(VSV-G) virus stock and transduced cells selected in 2.5 lg/ml
puromycin for approximately 10 d. From the puromycin-resistant
population comprising several hundred colonies, four single cell
clones were derived by limiting dilution and expanded in culture
(approximately 2 wk). Cellular DNA extracted from each clone
(Qiagen extraction kit, http://www.qiagen.com) was subjected to PCR
analysis using HERV-KCON gag-speciﬁc primers Gag-S (nucleotides
1236 to 1262, Figure S1) and Gag-AS (nucleotides 1991 to 1946,
Figure S1). Additionally, host DNA sequences ﬂanking the integrated
CHKCP proviral DNA were cloned using the GenomeWalker kit
(Clontech) according to the manufacturer’s instructions and PCR
primers directed to the HERV-KCON LTRs. Speciﬁcally, LTR-AS
(GCA AGA GAG ATC AGA TTG TTA CTG TGT CTG) and LTR-S
(TAC GAG AAA CAC CCA CAG GTG TGT AGG) oligonucleotides
were used to clone sequences ﬂanking the 59 and 39 LTRs,
respectively. Additional PCR primers, targeting ﬂanking hamster
DNA sequences identiﬁed via the GenomeWalker approach, were
used to authenticate the presence of preintegration sites in
uninfected CHO745 cells and integrated provirus in three CHKCP
transduced cell clones. In the example (clone No. 1) shown in Figure
4E, the primers Ham-S (GCT ACC CTG AAG ATT TGA GCC AGT
GTG C) and Ham-AS (TCT TGC AAG TTG TCC TGT GGC ATG G)
were used. For all PCRs, 30 cycles of ampliﬁcation were completed
using 200 ng of cellular DNA, with no DNA, uninfected CHO cell
DNA, or human DNA templates analyzed as negative and positive
controls, as appropriate.
Supporting Information
Figure S1. HERV-KCON Proviral Sequence
The complete 9,472-nucleotide provial sequence is shown. LTR
sequences are underlined. Protein sequences encoded by Gag, PR,
Pol, Env, and K-Rev ORFs are also shown.
Found at doi:10.1371/journal.ppat.0030010.sg001 (77 KB PDF).
Acknowledgments
We thank Daniel Boden for technical advice, David Perez-Caballero
for the TRIM5-expressing CHO745 cells, Theodora Hatziioannou for
reverse transcriptase assays, and Eleana Sphicas from the Rockefeller
University Bio-Imaging Resource Center for electron microscopy.
Author contributions. YNL and PDB conceived and designed the
experiments, performed the experiments, analyzed the data, and
wrote the paper.
Funding. This work was supported by US National Institutes of
Health (NIH) grant R01AI64003. YNL was supported in part by funds
from The Rockefeller University Women & Science Fellowship
Program. PDB is an Elizabeth Glaser Scientist of the Elisabeth Glaser
Pediatric AIDS Foundation.
Competing interests. The authors have declared that no competing
interests exist.
References
1. Bannert N, Kurth R (2004) Retroelements and the human genome: New
perspectives on an old relation. Proc Natl Acad Sci U S A 101 (Suppl 2):
14572–14579.
2. Lander ES, Linton LM, Birren B, Nusbaum C, Zody MC, et al. (2001) Initial
sequencing and analysis of the human genome. Nature 409: 860–921.
3. Barbulescu M, Turner G, Seaman MI, Deinard AS, Kidd KK, et al. (1999)
Many human endogenous retrovirus K (HERV-K) proviruses are unique to
humans. Curr Biol 9: 861–868.
4. Belshaw R, Dawson AL, Woolven-Allen J, Redding J, Burt A, et al. (2005)
Genomewide screening reveals high levels of insertional polymorphism in
the human endogenous retrovirus family HERV-K(HML2): Implications for
present-day activity. J Virol 79: 12507–12514.
5. Hughes JF, Cofﬁn JM (2004) Human endogenous retrovirus K solo-LTR
formation and insertional polymorphisms: Implications for human and
viral evolution. Proc Natl Acad Sci U S A 101: 1668–1672.
6. Turner G, Barbulescu M, Su M, Jensen-Seaman MI, Kidd KK, et al. (2001)
Insertional polymorphisms of full-length endogenous retroviruses in
humans. Curr Biol 11: 1531–1535.
7. Mallet F, Prudhomme S (2004) [Retroviral inheritance in man] [in French]. J
Soc Biol 198: 399–412.
8. Tonjes RR, Lower R, Boller K, Denner J, Hasenmaier B, et al. (1996) HERV-
K: The biologically most active human endogenous retrovirus family. J
Acquir Immune Deﬁc Syndr Hum Retrovirol 13 (Suppl 1): S261–S267.
9. Costas J (2002) Characterization of the intragenomic spread of the human
endogenous retrovirus family HERV-W. Mol Biol Evol 19: 526–533.
10. Belshaw R, Pereira V, Katzourakis A, Talbot G, Paces J, et al. (2004) Long-
term reinfection of the human genome by endogenous retroviruses. Proc
Natl Acad Sci U S A 101: 4894–4899.
11. Belshaw R, Katzourakis A, Paces J, Burt A, Tristem M (2005) High copy
number in human endogenous retrovirus families is associated with
copying mechanisms in addition to reinfection. Mol Biol Evol 22: 814–817.
12. OhAinle M, Kerns JA, Malik HS, Emerman M (2006) Adaptive evolution and
antiviral activity of the conserved mammalian cytidine deaminase
APOBEC3H. J Virol 80: 3853–3862.
13. Sawyer SL, Emerman M, Malik HS (2004) Ancient adaptive evolution of the
primate antiviral DNA-editing enzyme APOBEC3G. PLoS Biol 2: e275.
doi:10.1371/journal.pbio.0020275.
14. Sawyer SL, Wu LI, Emerman M, Malik HS (2005) Positive selection of
primate TRIM5alpha identiﬁes a critical species-speciﬁc retroviral restric-
tion domain. Proc Natl Acad Sci U S A 102: 2832–2837.
15. Song B, Gold B, O’Huigin C, Javanbakht H, Li X, et al. (2005) The
B30.2(SPRY) domain of the retroviral restriction factor TRIM5alpha
exhibits lineage-speciﬁc length and sequence variation in primates. J Virol
79: 6111–6121.
16. Conticello SG, Thomas CJ, Petersen-Mahrt SK, Neuberger MS (2005)
Evolution of the AID/APOBEC family of polynucleotide (deoxy)cytidine
deaminases. Mol Biol Evol 22: 367–377.
17. Kitamura Y, Ayukawa T, Ishikawa T, Kanda T, Yoshiike K (1996) Human
endogenous retrovirus K10 encodes a functional integrase. J Virol 70:
3302–3306.
18. Magin C, Hesse J, Lower J, Lower R (2000) Corf, the Rev/Rex homologue of
HTDV/HERV-K, encodes an arginine-rich nuclear localization signal that
exerts a trans-dominant phenotype when mutated. Virology 274: 11–16.
19. Yang J, Bogerd H, Le SY, Cullen BR (2000) The human endogenous
retrovirus K Rev response element coincides with a predicted RNA folding
region. RNA 6: 1551–1564.
20. Yang J, Bogerd HP, Peng S, Wiegand H, Truant R, et al. (1999) An ancient
family of human endogenous retroviruses encodes a functional homolog of
the HIV-1 Rev protein. Proc Natl Acad Sci U S A 96: 13404–13408.
21. Berkhout B, Jebbink M, Zsiros J (1999) Identiﬁcation of an active reverse
transcriptase enzyme encoded by a human endogenous HERV-K retrovirus.
J Virol 73: 2365–2375.
22. Dewannieux M, Blaise S, Heidmann T (2005) Identiﬁcation of a functional
envelope protein from the HERV-K family of human endogenous
retroviruses. J Virol 79: 15573–15577.
23. Towler EM, Gulnik SV, Bhat TN, Xie D, Gustschina E, et al. (1998)
Functional characterization of the protease of human endogenous
retrovirus, K10: Can it complement HIV-1 protease? Biochemistry 37:
17137–17144.
24. Mueller-Lantzsch N, Sauter M, Weiskircher A, Kramer K, Best B, et al.
(1993) Human endogenous retroviral element K10 (HERV-K10) encodes a
full-length gag homologous 73 kDa protein and a functional protease. AIDS
Res Hum Retroviruses 9: 343–350.
25. Harris JM, Haynes RH, McIntosh EM (1997) A consensus sequence for a
functional human endogenous retrovirus K (HERV-K) dUTPase. Biochem
Cell Biol 75: 143–151.
26. Boese A, Sauter M, Mueller-Lantzsch N (2000) A rev-like NES mediates
cytoplasmic localization of HERV-K cORF. FEBS Lett 468: 65–67.
27. Zennou V, Perez-Caballero D, Gottlinger H, Bieniasz PD (2004) APOBEC3G
incorporation into human immunodeﬁciency virus type 1 particles. J Virol
78: 12058–12061.
28. Bieda K, Hoffmann A, Boller K (2001) Phenotypic heterogeneity of human
endogenous retrovirus particles produced by teratocarcinoma cell lines. J
Gen Virol 82: 591–596.
29. Boller K, Konig H, Sauter M, Mueller-Lantzsch N, Lower R, et al. (1993)
Evidence that HERV-K is the endogenous retrovirus sequence that codes
for the human teratocarcinoma-derived retrovirus HTDV. Virology 196:
349–353.
30. Derse D, Hill SA, Lloyd PA, Chung H, Morse BA (2001) Examining human
T-lymphotropic virus type 1 infection and replication by cell-free infection
with recombinant virus vectors. J Virol 75: 8461–8468.
PLoS Pathogens | www.plospathogens.org January 2007 | Volume 3 | Issue 1 | e10 0129
Infectious HERV-K31. Rosenblum LL, Patton G, Grigg AR, Frater AJ, Cain D, et al. (2001)
Differential susceptibility of retroviruses to nucleoside analogues. Antivir
Chem Chemother 12: 91–97.
32. Saenz DT, Loewen N, Peretz M, Whitwam T, Barraza R, et al. (2004)
Unintegrated lentivirus DNA persistence and accessibility to expression in
nondividing cells: Analysis with class I integrase mutants. J Virol 78: 2906–
2920.
33. Yanez-Munoz RJ, Balaggan KS, MacNeil A, Howe SJ, Schmidt M, et al. (2006)
Effective gene therapy with nonintegrating lentiviral vectors. Nat Med 12:
348–353.
34. Wu Y, Marsh JW (2001) Selective transcription and modulation of resting T
cell activity by preintegrated HIV DNA. Science 293: 1503–1506.
35. Cello J, Paul AV, Wimmer E (2002) Chemical synthesis of poliovirus cDNA:
Generation of infectious virus in the absence of natural template. Science
297: 1016–1018.
36. Tumpey TM, Basler CF, Aguilar PV, Zeng H, Solorzano A, et al. (2005)
Characterization of the reconstructed 1918 Spanish inﬂuenza pandemic
virus. Science 310: 77–80.
37. Dewannieux M, Harper F, Richaud A, Letzelter C, Ribet D, et al. (2006)
Identiﬁcation of an infectious progenitor for the multiple-copy HERV-K
human endogenous retroelements. Genome Res 16: 1548–1556.
38. Ivics Z, Hackett PB, Plasterk RH, Izsvak Z (1997) Molecular reconstruction
of Sleeping Beauty, a Tc1-like transposon from ﬁsh, and its transposition in
human cells. Cell 91: 501–510.
39. Rhee SS, Hunter E (1990) A single amino acid substitution within the
matrix protein of a type D retrovirus converts its morphogenesis to that of
a type C retrovirus. Cell 63: 77–86.
40. Bieniasz PD (2004) Intrinsic immunity: A front-line defense against viral
attack. Nat Immunol 5: 1109–1115.
41. Stremlau M, Owens CM, Perron MJ, Kiessling M, Autissier P, et al. (2004)
The cytoplasmic body component TRIM5alpha restricts HIV-1 infection in
Old World monkeys. Nature 427: 848–853.
42. Sheehy AM, Gaddis NC, Choi JD, Malim MH (2002) Isolation of a human
gene that inhibits HIV-1 infection and is suppressed by the viral Vif
protein. Nature 418: 646–650.
43. Nisole S, Lynch C, Stoye JP, Yap MW (2004) A Trim5-cyclophilin A fusion
protein found in owl monkey kidney cells can restrict HIV-1. Proc Natl
Acad Sci U S A 101: 13324–13328.
44. Sayah DM, Sokolskaja E, Berthoux L, Luban J (2004) Cyclophilin A
retrotransposition into TRIM5 explains owl monkey resistance to HIV-1.
Nature 430: 569–573.
45. Mangeat B, Turelli P, Caron G, Friedli M, Perrin L, et al. (2003) Broad
antiretroviral defence by human APOBEC3G through lethal editing of
nascent reverse transcripts. Nature 424: 99–103.
46. Harris RS, Bishop KN, Sheehy AM, Craig HM, Petersen-Mahrt SK, et al.
(2003) DNA deamination mediates innate immunity to retroviral infection.
Cell 113: 803–809.
47. Lecossier D, Bouchonnet F, Clavel F, Hance AJ (2003) Hypermutation of
HIV-1 DNA in the absence of the Vif protein. Science 300: 1112.
48. Zhang H, Yang B, Pomerantz RJ, Zhang C, Arunachalam SC, et al. (2003)
The cytidine deaminase CEM15 induces hypermutation in newly synthe-
sized HIV-1 DNA. Nature 424: 94–98.
49. Bishop KN, Holmes RK, Sheehy AM, Malim MH (2004) APOBEC-mediated
editing of viral RNA. Science 305: 645.
50. Trono D (2004) Retroviruses under editing crossﬁre: A second member of
the human APOBEC3 family is a Vif-blockable innate antiretroviral factor.
EMBO Rep 5: 679–680.
51. Liddament MT, Brown WL, Schumacher AJ, Harris RS (2004) APOBEC3F
properties and hypermutation preferences indicate activity against HIV-1
in vivo. Curr Biol 14: 1385–1391.
52. Bishop KN, Holmes RK, Sheehy AM, Davidson NO, Cho SJ, et al. (2004)
Cytidine deamination of retroviral DNA by diverse APOBEC proteins. Curr
Biol 14: 1392–1396.
53. Zennou V, Bieniasz PD (2006) Comparative analysis of the antiretroviral
activity of APOBEC3G and APOBEC3F from primates. Virology 349: 31–40.
54. Cullen BR (2006) Role and mechanism of action of the APOBEC3 family of
antiretroviral resistance factors. J Virol 80: 1067–1076.
55. Rose PP, Korber BT (2000) Detecting hypermutations in viral sequences
with an emphasis on G ! A hypermutation. Bioinformatics 16: 400–401.
56. Neil SJ, Eastman SW, Jouvenet N, Bieniasz PD (2006) HIV-1 Vpu promotes
release and prevents endocytosis of nascent retrovirus particles from the
plasma membrane. PLoS Pathog 2: e39. doi:10.1371/journal.ppat.0020039.
PLoS Pathogens | www.plospathogens.org January 2007 | Volume 3 | Issue 1 | e10 0130
Infectious HERV-K